Global Veterinary Drugs Market size was valued at USD 37.58 Bn in 2023 and is expected to reach USD 54.67 Bn by 2030, at a CAGR of 5.5%.Veterinary Drugs Market Overview
Veterinary drugs constitute a fundamental aspect of animal husbandry and food production, facilitating animal health and productivity. Their usage leads to the presence of residues in animal-derived foods, heightening potential safety risks for consumers. To mitigate these concerns, national regulatory authorities enforce rigorous controls governing the authorization, labeling, and application of veterinary drugs in food-producing animals. Stringent guidelines and protocols oversee their use, ensuring adherence to safety standards and minimizing residual presence in food products. Advanced surveillance programs vigilantly monitor and test for any unsafe drug residues in animal-derived foods, employing sophisticated detection methodologies to maintain consumer safety. These surveillance initiatives within the Veterinary Drugs Market are critical in safeguarding public health and promptly detecting any breaches or deviations from established safety parameters. The Market growth is driven by several factors such as increasing demand for animal protein, rising pet ownership, and a growing focus on animal health and welfare. As the global population and disposable incomes increase, the demand for animal-derived products, such as meat, milk, and eggs, has surged. This, in turn, drives the need for veterinary drugs to ensure the health and well-being of food-producing animals. The growing trend of pet humanization, wherein pets are considered integral family members, contributes to an increasing emphasis on their healthcare. Opportunities within the Veterinary Drugs Market arise from advancements in veterinary pharmaceuticals, including novel drug developments and biotechnological innovations. As companion animal populations expand, so does the demand for preventive and therapeutic veterinary medications. The industry is witnessing trends toward sustainable and organic farming practices, influencing the use of pharmaceuticals in livestock management. The integration of technology, such as precision farming and telemedicine, enhances the efficiency of veterinary drug administration.To know about the Research Methodology :- Request Free Sample Report
Veterinary Drugs Market Trend
Increasing Focus on Preventive Healthcare for Animals The growing emphasis on preventive healthcare for animals’ inscriptions is a shift from reactive strategies to a proactive approach, centered around vaccinations, regular check-ups and preventive measures. Veterinarians advocate for frequent screenings and vaccinations to safeguard animal welfare and reduce disease instances. This trend highlights the importance of early intervention and consistent health monitoring to prevent conditions from worsening. It's a model that not only improves animal health but also reduces the requirement for extensive and costly treatments which boosts the Veterinary Drugs Market growth. By prioritizing preventive measures, the veterinary industry goals to instill a culture of proactive care, promoting healthier lives for animals while potentially easing the financial burden linked with reactive treatments. This signifies a broader outlook in veterinary medicine, emphasizing a dedication to ensuring ongoing animal health and well-being through proactive and comprehensive healthcare practices.Veterinary Drugs Market Dynamics
Increasing Demand for Animal Protein Globally to Drive Market Growth The Veterinary Drugs Market is significantly driven by the surging global demand for animal protein. As the world population burgeons and dietary habits evolve, there's an exponential rise in the consumption of meat, milk, and eggs. This increasing demand for animal protein necessitates a strong and healthy livestock industry capable of meeting these dietary needs. Veterinary drug's in ensuring the health, well-being and productivity of food-producing animals. They serve as a cornerstone in maintaining animal health, preventing diseases, managing infections, promoting growth, and enhancing reproductive health among livestock. By addressing these animal health concerns, the veterinary drugs industry effectively mitigates the risk of diseases that potentially affect human health through foodborne pathogens, thereby bolstering food safety. The essentiality of veterinary drugs in modern food production systems is evident in their multifaceted roles, ensuring the sustained health and productivity of food-producing animals to meet the soaring demands for animal-derived protein. The perpetual necessity to maintain and optimize animal health standards, and secure a safe and ample supply of animal protein boosts the Veterinary Drugs Market growth. The import value of veterinary drugs in Thailand has seen growth in line with the increasing global demand for animal protein. This surge in demand is a key factor boosting growth within the Market, signaling promising prospects for the industry.The advancement of personalized medicine for animals is a Lucrative opportunity for the market Advancing personalized veterinary medicine tailors’ treatments to individual animal traits, genetics, and health, akin to human healthcare's personalized approach. This evolution is a promising opportunity within the Veterinary Drugs Market, focusing on customized care for each animal's unique needs and characteristics. This shift from a one-size-fits-all approach to customized treatments offers substantial benefits. It allows for precise and targeted therapies, addressing specific ailments or conditions in animals with greater accuracy while minimizing potential side effects. The integration of cutting-edge technologies, such as genomics, diagnostics, and therapeutic interventions, plays a pivotal role in this development. As these tools advance, they provide the potential for innovative drug formulations and therapies designed to meet the unique needs of each animal, elevating the efficacy of veterinary drugs. Embracing personalized medicine in animal healthcare not only enhances treatment outcomes but also signifies a promising avenue for growth and innovation in the Veterinary Drugs Market, shaping the future landscape of veterinary care. Regulatory complexities and stringent approval processes hamper Market Growth Navigating the intricate web of stringent regulations set by national and international bodies bringing veterinary drugs to market. Compliance demands meticulous attention to safety, efficacy, and quality, driving extensive testing, clinical trials, and detailed documentation for approval. These processes often lead to prolonged timelines for new drug introductions, elongating development phases and requiring significant financial investments. Compounded by varying regulatory mandates globally, manufacturers face complex approval procedures across different regions, creating formidable barriers to rapid market entry of innovative veterinary drugs. This involves landscape impedes the rapid rollout of new treatments for animal health, hindering Veterinary Drugs Market growth. The prolonged approval cycles not only delay access to advanced therapies but also present financial and logistical challenges for companies striving to launch new drugs into the market.
Veterinary Drugs Market Segment Analysis
Based on the Product, the market is segmented into Anti-infectives, Anti-inflammatory, Parasiticides and Others. Parasiticides are expected to dominate the Veterinary Drugs Market over the forecast period. Parasiticides stand as the cornerstone product in the Market, addressing threats from external parasites like ticks, fleas, and mosquitoes. These pests swiftly transmit diseases and create widespread outbreaks, prompting vigilant farming practices that prioritize the use of parasiticides to safeguard animal health. For internal parasites such as worms, essential in livestock, anthelmintics maintain weight and bolster milk production in cattle. Pet owners also rely on these crucial treatments, guided by veterinarians, to combat threats such as fleas and heartworms. Innovation within parasiticides continues to focus on tackling resistance and sustainability challenges. Yet, the aftermath of these drugs in the environment underscores the need for careful consideration post-use. Emphasizing individual risk assessments for prescribing parasiticides challenges the prevalent blanket use, advocating tailored, informed decisions shaped by independent veterinary sources such as Veterinary Prescriber. Parasitic infections pose significant threats to animal health worldwide. They affect various species, causing diseases that impact livestock productivity, companion animal well-being, and, in some cases, human health. Parasiticides play a crucial role in preventing, controlling, and treating these infections. Parasiticides within the Veterinary Drugs Market exhibit versatility by effectively combating a wide spectrum of parasites, encompassing both internal and external varieties such as worms, ticks, fleas, mites, and others. This broad applicability renders them indispensable in managing diverse parasitic infections across various animal species. Parasiticides are employed not only for treatment but also as preventive measures. Regular use helps avert infestations, reducing disease transmission, and preventing the onset of severe health issues caused by parasites. In the context of livestock farming, parasitic infections have a significant economic impact. Parasiticides are critical in maintaining animal health, and preventing production losses due to decreased feed conversion, reduced weight gain, lower milk yield, and other health-related issues.North America is expected to dominate the Veterinary Drugs Market over the forecast period. The region's leadership stems from a combination of strong pet ownership trends, advanced healthcare infrastructure, stringent regulatory frameworks, and a culture that prioritizes animal health and well-being. The United States and Canada have witnessed a steady increase in the number of companion animals, including dogs, cats and other small mammals, which translates into an increasing demand for veterinary drugs. This inclination towards responsible pet ownership boosts the need for a wide array of pharmaceuticals and healthcare services aimed at maintaining the health and longevity of these beloved animals. North America boasts a highly developed and sophisticated veterinary healthcare infrastructure. Renowned for its state-of-the-art veterinary clinics, hospitals, and research institutions, the region fosters an environment conducive to innovation and cutting-edge developments in veterinary medicine. These facilities not only facilitate the diagnosis and treatment of various animal diseases but also serve as hubs for research and development in veterinary pharmaceuticals. Stringent regulatory standards in North America's dominance in the Veterinary Drugs Market. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and Health Canada impose rigorous standards for the approval, safety, and efficacy of veterinary drugs. The stringent oversight ensures the quality and safety of pharmaceutical products, instilling confidence among consumers, veterinarians, and stakeholders in the industry. North America's proactive approach to animal health and welfare further cements its dominance. The region's commitment to preventive healthcare for animals includes regular wellness check-ups, vaccinations, and disease prevention programs. This emphasis on early intervention and disease prevention not only ensures the well-being of animals but also drives the demand for a wide range of veterinary pharmaceuticals.
Veterinary Drugs Market Regional Insights
Veterinary Drugs Market Scope: Inquire before buying
Global Veterinary Drugs Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 37.58 Bn. Forecast Period 2024 to 2030 CAGR: 5.5% Market Size in 2030: US $ 54.67 Bn. Segments Covered: By Product Anti-infectives Anti-inflammatory Parasiticides Others By Animal Companion Livestock Others By Route of Administration Oral Injectable Topical Others By Distribution Channel Veterinary Clinics and Hospitals Retail Pharmacies and Veterinary Pharmacies Online Pharmacies and E-commerce Platforms Others Global Veterinary Drugs Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Veterinary Drugs Market Key Players
Global 1. Zoetis Inc. (Parsippany, New Jersey, USA) 2. Boehringer Ingelheim Animal Health (Ingelheim am Rhein, Germany) 3. Elanco Animal Health (Greenfield, Indiana, USA) 4. Merck Animal Health (Madison, New Jersey, USA) 5. Bayer Animal Health (Monheim am Rhein, Germany) North America 1. Heska Corporation (Loveland, Colorado, USA) 2. Phibro Animal Health Corporation (Teaneck, New Jersey, USA) Europe 1. Vetoquinol (Lure, France) 2. Virbac (Carros, France) 3. Ceva Santé Animale (Libourne, France) 4. Dechra Pharmaceuticals (Northwich, United Kingdom) 5. Norbrook Laboratories (Newry, Northern Ireland, UK) 6. Chanelle Pharma (Loughrea, Ireland) 7. Bimeda (Carrickmines, Ireland) 8. Hipra (Amer, Spain) 9. Nexvet (Tullamore, Ireland) 10. Simini (Villeneuve-sur-Lot, France) 11. Nexvet (Tullamore, Ireland) 12. Dopharma (Raamsdonksveer, Netherlands) Asia Pacific 1. Kyoritsu Seiyaku Corporation (Tokyo, Japan) 2. Huvepharma (Sofia, Bulgaria) 3. Troy Laboratories (Glendenning, Australia)Frequently Asked Questions:
1] What is the growth rate of the Global Veterinary Drugs Market? Ans. The Global Veterinary Drugs Market is growing at a significant rate of 5.5% during the forecast period. 2] Which region is expected to dominate the Global Veterinary Drugs Market? Ans. North America is expected to dominate the Veterinary Drugs Market during the forecast period. 3] What is the expected Global Veterinary Drugs Market size by 2030? Ans. The Veterinary Drugs Market size is expected to reach USD 54.67 Billion by 2030. 4] Which are the top players in the Global Veterinary Drugs Market? Ans. The major top players in the Global Veterinary Drugs Market are Zoetis Inc. (Parsippany, New Jersey, USA), Boehringer Ingelheim Animal Health (Ingelheim am Rhein, Germany),lanco Animal Health (Greenfield, Indiana, USA),Merck Animal Health (Madison, New Jersey, USA) and Others. 5] What are the factors driving the Global Veterinary Drugs Market growth? Ans. Increasing pet adoption rates worldwide, leading to heightened demand for companion animal healthcare products and the rising prevalence of zoonotic diseases are expected to drive market growth during the forecast period.
1. Veterinary Drugs Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Veterinary Drugs Market: Dynamics 2.1. Market Trends by Region 2.1.1. North America 2.1.2. Europe 2.1.3. Asia Pacific 2.1.4. Middle East and Africa 2.1.5. South America 2.2. Market Dynamics by Region 2.2.1. North America 2.2.1.1. Drivers 2.2.1.2. Restraints 2.2.1.3. Opportunities 2.2.1.4. Challenges 2.2.2. Europe 2.2.2.1. Drivers 2.2.2.2. Restraints 2.2.2.3. Opportunities 2.2.2.4. Challenges 2.2.3. Asia Pacific 2.2.3.1. Drivers 2.2.3.2. Restraints 2.2.3.3. Opportunities 2.2.3.4. Challenges 2.2.4. Middle East and Africa 2.2.4.1. Drivers 2.2.4.2. Restraints 2.2.4.3. Opportunities 2.2.4.4. Challenges 2.2.5. South America 2.2.5.1. Drivers 2.2.5.2. Restraints 2.2.5.3. Opportunities 2.2.5.4. Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Value Chain Analysis 2.6. Technological Roadmap 2.7. Regulatory Landscape by Region 2.7.1. North America 2.7.2. Europe 2.7.3. Asia Pacific 2.7.4. Middle East and Africa 2.7.5. South America 2.8. Analysis of Government Schemes and Initiatives For Veterinary Drugs Industry 2.9. Key Opinion Leader Analysis 2.10. The Global Pandemic Impact on Veterinary Drugs Market 3. Veterinary Drugs Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 3.1. Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 3.1.1. Anti-infectives 3.1.2. Anti-inflammatory 3.1.3. Parasiticides 3.1.4. Others 3.2. Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 3.2.1. Companion 3.2.2. Livestock 3.2.3. Others 3.3. Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 3.3.1. Oral 3.3.2. Injectable 3.3.3. Topical 3.3.4. Others 3.4. Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 3.4.1. Veterinary Clinics and Hospitals 3.4.2. Retail Pharmacies and Veterinary Pharmacies 3.4.3. Online Pharmacies and E-commerce Platforms 3.4.4. Others 3.5. Veterinary Drugs Market Size and Forecast, By Region (2023-2030) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Veterinary Drugs Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 4.1. North America Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 4.1.1. Anti-infectives 4.1.2. Anti-inflammatory 4.1.3. Parasiticides 4.1.4. Others 4.2. North America Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 4.2.1. Companion 4.2.2. Livestock 4.2.3. Others 4.3. North America Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 4.3.1. Oral 4.3.2. Injectable 4.3.3. Topical 4.3.4. Others 4.4. North America Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 4.4.1. Veterinary Clinics and Hospitals 4.4.2. Retail Pharmacies and Veterinary Pharmacies 4.4.3. Online Pharmacies and E-commerce Platforms 4.4.4. Others 4.5. North America Veterinary Drugs Market Size and Forecast, by Country (2023-2030) 4.5.1. United States 4.5.1.1. United States Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 4.5.1.1.1. Anti-infectives 4.5.1.1.2. Anti-inflammatory 4.5.1.1.3. Parasiticides 4.5.1.1.4. Others 4.5.1.2. United States Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 4.5.1.2.1. Companion 4.5.1.2.2. Livestock 4.5.1.2.3. Others 4.5.1.3. United States Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 4.5.1.3.1. Oral 4.5.1.3.2. Injectable 4.5.1.3.3. Topical 4.5.1.3.4. Others 4.5.1.3.5. 4.5.1.4. United States Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 4.5.1.4.1. Veterinary Clinics and Hospitals 4.5.1.4.2. Retail Pharmacies and Veterinary Pharmacies 4.5.1.4.3. Online Pharmacies and E-commerce Platforms 4.5.1.4.4. Others 4.5.2. Canada 4.5.2.1. Canada Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 4.5.2.1.1. Anti-infectives 4.5.2.1.2. Anti-inflammatory 4.5.2.1.3. Parasiticides 4.5.2.1.4. Others 4.5.2.2. Canada Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 4.5.2.2.1. Companion 4.5.2.2.2. Livestock 4.5.2.2.3. Others 4.5.2.3. Canada Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 4.5.2.3.1. Oral 4.5.2.3.2. Injectable 4.5.2.3.3. Topical 4.5.2.3.4. Others 4.5.2.4. Canada Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 4.5.2.4.1. Veterinary Clinics and Hospitals 4.5.2.4.2. Retail Pharmacies and Veterinary Pharmacies 4.5.2.4.3. Online Pharmacies and E-commerce Platforms 4.5.2.4.4. Others 4.5.3. Mexico 4.5.3.1. Mexico Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 4.5.3.1.1. Anti-infectives 4.5.3.1.2. Anti-inflammatory 4.5.3.1.3. Parasiticides 4.5.3.1.4. Others 4.5.3.2. Mexico Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 4.5.3.2.1. Companion 4.5.3.2.2. Livestock 4.5.3.2.3. Others 4.5.3.3. Mexico Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 4.5.3.3.1. Oral 4.5.3.3.2. Injectable 4.5.3.3.3. Topical 4.5.3.3.4. Others 4.5.3.4. Mexico Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 4.5.3.4.1. Veterinary Clinics and Hospitals 4.5.3.4.2. Retail Pharmacies and Veterinary Pharmacies 4.5.3.4.3. Online Pharmacies and E-commerce Platforms 4.5.3.4.4. Others 5. Europe Veterinary Drugs Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 5.1. Europe Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 5.2. Europe Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 5.3. Europe Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 5.4. Europe Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.5. Europe Veterinary Drugs Market Size and Forecast, by Country (2023-2030) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 5.5.1.2. United Kingdom Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 5.5.1.3. United Kingdom Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 5.5.1.4. United Kingdom Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.5.2. France 5.5.2.1. France Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 5.5.2.2. France Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 5.5.2.3. France Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 5.5.2.4. France Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.5.3. Germany 5.5.3.1. Germany Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 5.5.3.2. Germany Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 5.5.3.3. Germany Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 5.5.3.4. Germany Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.5.4. Italy 5.5.4.1. Italy Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 5.5.4.2. Italy Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 5.5.4.3. Italy Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 5.5.4.4. Italy Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.5.5. Spain 5.5.5.1. Spain Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 5.5.5.2. Spain Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 5.5.5.3. Spain Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 5.5.5.4. Spain Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.5.6. Sweden 5.5.6.1. Sweden Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 5.5.6.2. Sweden Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 5.5.6.3. Sweden Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 5.5.6.4. Sweden Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.5.7. Austria 5.5.7.1. Austria Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 5.5.7.2. Austria Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 5.5.7.3. Austria Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 5.5.7.4. Austria Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 5.5.8.2. Rest of Europe Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 5.5.8.3. Rest of Europe Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 5.5.8.4. Rest of Europe Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6. Asia Pacific Veterinary Drugs Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 6.1. Asia Pacific Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.2. Asia Pacific Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.3. Asia Pacific Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.4. Asia Pacific Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.5. Asia Pacific Veterinary Drugs Market Size and Forecast, by Country (2023-2030) 6.5.1. China 6.5.1.1. China Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.5.1.2. China Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.5.1.3. China Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.5.1.4. China Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.5.2. S Korea 6.5.2.1. S Korea Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.5.2.2. S Korea Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.5.2.3. S Korea Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.5.2.4. S Korea Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.5.3. Japan 6.5.3.1. Japan Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.5.3.2. Japan Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.5.3.3. Japan Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.5.3.4. Japan Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.5.4. India 6.5.4.1. India Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.5.4.2. India Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.5.4.3. India Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.5.4.4. India Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.5.5. Australia 6.5.5.1. Australia Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.5.5.2. Australia Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.5.5.3. Australia Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.5.5.4. Australia Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.5.6. Indonesia 6.5.6.1. Indonesia Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.5.6.2. Indonesia Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.5.6.3. Indonesia Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.5.6.4. Indonesia Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.5.7. Malaysia 6.5.7.1. Malaysia Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.5.7.2. Malaysia Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.5.7.3. Malaysia Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.5.7.4. Malaysia Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.5.8. Vietnam 6.5.8.1. Vietnam Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.5.8.2. Vietnam Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.5.8.3. Vietnam Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.5.8.4. Vietnam Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.5.9. Taiwan 6.5.9.1. Taiwan Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.5.9.2. Taiwan Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.5.9.3. Taiwan Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.5.9.4. Taiwan Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 6.5.10.2. Rest of Asia Pacific Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 6.5.10.3. Rest of Asia Pacific Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 6.5.10.4. Rest of Asia Pacific Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7. Middle East and Africa Veterinary Drugs Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030 7.1. Middle East and Africa Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 7.2. Middle East and Africa Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 7.3. Middle East and Africa Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 7.4. Middle East and Africa Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.5. Middle East and Africa Veterinary Drugs Market Size and Forecast, by Country (2023-2030) 7.5.1. South Africa 7.5.1.1. South Africa Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 7.5.1.2. South Africa Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 7.5.1.3. South Africa Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 7.5.1.4. South Africa Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.5.2. GCC 7.5.2.1. GCC Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 7.5.2.2. GCC Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 7.5.2.3. GCC Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 7.5.2.4. GCC Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.5.3. Nigeria 7.5.3.1. Nigeria Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 7.5.3.2. Nigeria Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 7.5.3.3. Nigeria Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 7.5.3.4. Nigeria Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 7.5.4.2. Rest of ME&A Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 7.5.4.3. Rest of ME&A Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 7.5.4.4. Rest of ME&A Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 8. South America Veterinary Drugs Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030 8.1. South America Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 8.2. South America Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 8.3. South America Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 8.4. South America Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 8.5. South America Veterinary Drugs Market Size and Forecast, by Country (2023-2030) 8.5.1. Brazil 8.5.1.1. Brazil Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 8.5.1.2. Brazil Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 8.5.1.3. Brazil Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 8.5.1.4. Brazil Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 8.5.2. Argentina 8.5.2.1. Argentina Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 8.5.2.2. Argentina Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 8.5.2.3. Argentina Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 8.5.2.4. Argentina Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Veterinary Drugs Market Size and Forecast, By Product (2023-2030) 8.5.3.2. Rest Of South America Veterinary Drugs Market Size and Forecast, By Animal (2023-2030) 8.5.3.3. Rest Of South America Veterinary Drugs Market Size and Forecast, By Route of Administration (2023-2030) 8.5.3.4. Rest Of South America Veterinary Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 9. Global Veterinary Drugs Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Service Segment 9.3.3. Product Segment 9.3.4. Revenue (2022) 9.3.5. Manufacturing Locations 9.4. Leading Veterinary Drugs Market Companies, by Market Capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Zoetis Inc. (Parsippany, New Jersey, USA) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Zoetis Inc. (Parsippany, New Jersey, USA) 10.3. Boehringer Ingelheim Animal Health (Ingelheim am Rhein, Germany) 10.4. Elanco Animal Health (Greenfield, Indiana, USA) 10.5. Merck Animal Health (Madison, New Jersey, USA) 10.6. Bayer Animal Health (Monheim am Rhein, Germany) 10.7. Heska Corporation (Loveland, Colorado, USA) 10.8. Phibro Animal Health Corporation (Teaneck, New Jersey, USA) 10.9. Vetoquinol (Lure, France) 10.10. Virbac (Carros, France) 10.11. Ceva Santé Animale (Libourne, France) 10.12. Dechra Pharmaceuticals (Northwich, United Kingdom) 10.13. Norbrook Laboratories (Newry, Northern Ireland, UK) 10.14. Chanelle Pharma (Loughrea, Ireland) 10.15. Bimeda (Carrickmines, Ireland) 10.16. Hipra (Amer, Spain) 10.17. Nexvet (Tullamore, Ireland) 10.18. Simini (Villeneuve-sur-Lot, France) 10.19. Nexvet (Tullamore, Ireland) 10.20. Dopharma (Raamsdonksveer, Netherlands) 10.21. Kyoritsu Seiyaku Corporation (Tokyo, Japan) 10.22. Huvepharma (Sofia, Bulgaria) 10.23. Troy Laboratories (Glendenning, Australia) 11. Key Findings 12. Industry Recommendations 13. Veterinary Drugs Market: Research Methodology